文献速递消化系统肿瘤

大型日本人群中支链氨基酸血浆浓度与结直肠腺瘤风险的相关性

Association of plasma concentrations of branched-chain amino acids with risk of colorectal adenoma in a large Japanese population.
PubMed 文献 · Ann Oncol · 2017-01-01

该研究基于2004至2005年癌症筛查中接受全结肠镜检查的日本人群,纳入629例结直肠腺瘤患者和584例对照,检测血浆亮氨酸、异亮氨酸和缬氨酸浓度。多因素调整后,高血浆亮氨酸、缬氨酸和总支链氨基酸与结直肠腺瘤风险呈负相关,该负相关在男性中明显,在女性中不明显。作者认为支链氨基酸可能对结直肠癌变早期阶段有益,但机制需进一步研究。

要点

  • 高血浆亮氨酸与结直肠腺瘤风险降低相关,最高与最低四分位比较OR为0.60(95%CI 0.42-0.87,Ptrend=0.006)。
  • 高血浆缬氨酸和总支链氨基酸与结直肠腺瘤风险呈负相关,OR分别为0.68(95%CI 0.48-0.97)和0.68(95%CI 0.48-0.98)。
  • 该负相关在男性中明显,在女性中不明显。

核心结论

  • 研究结果提示支链氨基酸可能对结直肠癌变过程有益,至少在其早期阶段。
  • 支链氨基酸与结直肠癌变之间这种潜在关联的机制需进一步研究。

研究设计与样本

  • 从2004至2005年接受全结肠镜检查作为癌症筛查项目一部分并回答自填饮食和生活方式问卷的受检者中识别结直肠腺瘤病例和对照。
  • 测量629例腺瘤患者和584例对照的血浆亮氨酸、异亮氨酸和缬氨酸浓度。
  • 采用非条件logistic回归模型估计调整潜在混杂因素后支链氨基酸与结直肠腺瘤风险关联的比值比(OR)和95%置信区间(CI)。

主要发现

  • 调整潜在混杂因素后,高血浆亮氨酸、缬氨酸和总支链氨基酸浓度与结直肠腺瘤风险呈负相关。
  • 最高与最低四分位比较,多因素调整OR:亮氨酸0.60(95%CI 0.42-0.87,Ptrend=0.006),缬氨酸0.68(95%CI 0.48-0.97,Ptrend=0.09),总支链氨基酸0.68(95%CI 0.48-0.98,Ptrend=0.10)。
  • 按性别进一步分析,该负相关在男性中明显,在女性中不明显:男性亮氨酸、缬氨酸和总支链氨基酸的相应OR分别为0.50(95%CI 0.32-0.80,Ptrend=0.003)、0.60(95%CI 0.38-0.95,Ptrend=0.01)和0.58(95%CI 0.37-0.93,Ptrend=0.04);女性分别为0.78(95%CI 0.42-1.45,Ptrend=0.44)、0.77(95%CI 0.41-1.43,Ptrend=0.85)和0.84(95%CI 0.45-1.57,Ptrend=0.81)。

局限性

  • 支链氨基酸与结直肠癌变之间这种潜在关联的机制需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Available evidence from animal studies suggests that branched-chain amino acids (BCAAs) may have a protective effect against colorectal carcinogenesis. However, a possible effect of BCAAs against colorectal neoplasia has not been evaluated in humans. Here, we aimed to evaluate whether plasma concentrations of BCAA are associated with the risk of colorectal adenoma (CRA), a precursor lesion of colorectal cancer. PATIENTS AND METHODS: CRA cases and controls were identified from examinees who underwent total colonoscopy as part of a cancer screening program between 2004 and 2005 and responded to self-administered dietary and lifestyle questionnaires. We measured plasma concentrations of leucine, isoleucine and valine in 629 patients with adenoma and 584 controls. Unconditional logistic regression models were used to estimate odds ratio (OR) and 95% confidence interval (CI) for the association between BCAA and CRA risk after adjustment for potential confounders. RESULTS: High plasma concentrations of leucine, valine and total BCAA were inversely associated with CRA risk after adjustment of potential confounders. The multivariate-adjusted ORs for the highest versus lowest quartiles were 0.60 (95% CI 0.42-0.87, Ptrend = 0.006) for leucine, 0.68 (95% CI 0.48-0.97, Ptrend = 0.09) for valine and 0.68 (95% CI 0.48-0.98, Ptrend = 0.10) for total BCAA. Further analysis by gender revealed that this inverse association was clearly evident in men, but not in women: the corresponding OR for leucine, valine and total BCAA was 0.50 (95% CI 0.32-0.80, Ptrend = 0.003), 0.60 (95% CI 0.38-0.95, Ptrend = 0.01) and 0.58 (95% CI 0.37-0.93, Ptrend = 0.04), respectively, in men and 0.78 (95% CI 0.42-1.45, Ptrend = 0.44), 0.77 (95% CI 0.41-1.43, Ptrend = 0.85) and 0.84 (95% CI 0.45-1.57, Ptrend = 0.81), respectively, in women. CONCLUSION: Our finding suggests that BCAAs may have a beneficial influence against the process of colorectal carcinogenesis, at least in the early stage. The mechanisms underlying this potential association between BCAA and colorectal carcinogenesis warrant further investigation.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Budhathoki S, Iwasaki M, Yamaji T, et al. Association of plasma concentrations of branched-chain amino acids with risk of colorectal adenoma in a large Japanese population. Ann Oncol. 2017. PMID: 28011449. doi:10.1093/annonc/mdw680

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。